- Home
- Publications
- Publication Search
- Publication Details
Title
Role of RAGE in Alzheimer’s Disease
Authors
Keywords
Alzheimer’s disease, Receptor for advanced glycation end products, Beta-amyloid, Tau hyperphosphorylation, Cognitive impairment
Journal
CELLULAR AND MOLECULAR NEUROBIOLOGY
Volume 36, Issue 4, Pages 483-495
Publisher
Springer Nature
Online
2015-07-14
DOI
10.1007/s10571-015-0233-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial Alterations, Oxidative Stress and Neuroinflammation in Alzheimer's Disease
- (2017) M. Verri et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- The Damage Signals Hypothesis of Alzheimer's Disease Pathogenesis
- (2017) Jorge A. Fernández et al. JOURNAL OF ALZHEIMERS DISEASE
- Mild Cognitive Impairment Due to Alzheimer Disease is Less Likely Under the Age of 65
- (2015) Soojeong Shin et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Increased tau phosphorylation and receptor for advanced glycation endproducts (RAGE) in the brain of mice infected with Leishmania amazonensis
- (2015) Juciano Gasparotto et al. BRAIN BEHAVIOR AND IMMUNITY
- Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
- (2015) Sho-ichi Yamagishi et al. Cardiovascular Diabetology
- Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain
- (2015) Angela Kuhla et al. NEUROBIOLOGY OF AGING
- Multi-faced neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model
- (2015) Cui Lv et al. NEUROPHARMACOLOGY
- Low Glucose Degradation Product Peritoneal Dialysis Regimen Is Associated With Lower Plasma EN-RAGE and HMGB-1 Proinflammatory Ligands of Receptor for Advanced Glycation End Products
- (2015) Sylvie Opatrna et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Differential impact of glucose levels and advanced glycation end-products on tubular cell viability and pro-inflammatory/profibrotic functions
- (2014) Benoit Franko et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- cAMP ameliorates inflammation by modulation of macrophage receptor for advanced glycation end-products
- (2014) So Motoyoshi et al. BIOCHEMICAL JOURNAL
- Brain metabolic dysfunction at the core of Alzheimer's disease
- (2014) Suzanne M. de la Monte et al. BIOCHEMICAL PHARMACOLOGY
- The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs
- (2014) Jing Xue et al. BIOCHEMISTRY
- Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood–brain barrier model
- (2014) Hisham Qosa et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach
- (2014) Parveen Salahuddin et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies
- (2014) Ying Dai et al. CNS & Neurological Disorders-Drug Targets
- Molecular Linkages Between Diabetes and Alzheimer's Disease: Current Scenario and Future Prospects
- (2014) Tanveer Dar et al. CNS & Neurological Disorders-Drug Targets
- Humanin: A Possible Linkage Between Alzheimer’s Disease and Type 2 Diabetes
- (2014) Hamidreza Mahboobi et al. CNS & Neurological Disorders-Drug Targets
- Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease
- (2014) Wei-wei Zhou et al. FREE RADICAL BIOLOGY AND MEDICINE
- Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model
- (2014) John W. Steele et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Mild Cognitive Impairment and Asymptomatic Alzheimer Disease Subjects
- (2014) Diego Iacono et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Activation of Neurotensin Receptor 1 Facilitates Neuronal Excitability and Spatial Learning and Memory in the Entorhinal Cortex: Beneficial Actions in an Alzheimer's Disease Model
- (2014) Z. Xiao et al. JOURNAL OF NEUROSCIENCE
- Dietary Intake of Advanced Glycation End Products Did Not Affect Endothelial Function and Inflammation in Healthy Adults in a Randomized Controlled Trial
- (2014) Richard D. Semba et al. JOURNAL OF NUTRITION
- Two Soluble Isoforms of Receptors for Advanced Glycation End Products (RAGE) in Carotid Atherosclerosis: The Difference of Soluble and Endogenous Secretory RAGE
- (2014) Saori Moriya et al. Journal of Stroke & Cerebrovascular Diseases
- Overexpression of Receptor for Advanced Glycation End Products and High-Mobility Group Box 1 in Human Dental Pulp Inflammation
- (2014) Salunya Tancharoen et al. MEDIATORS OF INFLAMMATION
- The interplay between hyperglycemia-induced oxidative stress markers and the level of soluble receptor for advanced glycation end products (sRAGE) in K562 cells
- (2014) Farnosh Shemirani et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits
- (2014) Rui Liu et al. NEUROBIOLOGY OF AGING
- Monomeric Aβ1–42 and RAGE: key players in neuronal differentiation
- (2014) Sabrina Piras et al. NEUROBIOLOGY OF AGING
- Clinical trial of an inhibitor of RAGE-A interactions in Alzheimer disease
- (2014) D. Galasko et al. NEUROLOGY
- Chronic Neurodegeneration After Traumatic Brain Injury: Alzheimer Disease, Chronic Traumatic Encephalopathy, or Persistent Neuroinflammation?
- (2014) Alan I. Faden et al. Neurotherapeutics
- Relationships Between Balance and Cognition in Patients With Subjective Cognitive Impairment, Mild Cognitive Impairment, and Alzheimer Disease
- (2014) G. G. Tangen et al. PHYSICAL THERAPY
- The Homologous Carboxyl-Terminal Domains of Microtubule-Associated Protein 2 and TAU Induce Neuronal Dysfunction and Have Differential Fates in the Evolution of Neurofibrillary Tangles
- (2014) Ce Xie et al. PLoS One
- Soluble receptor for advanced glycation end products (sRAGE) attenuates haemodynamic changes to chronic hypoxia in the mouse
- (2014) David G.S. Farmer et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease
- (2014) Romy M. Heilmann et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague–Dawley rats
- (2014) Lei Xu et al. Diabetology & Metabolic Syndrome
- Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex – evidence from two transgenic mouse models
- (2014) Sivaraman Purushothuman et al. Alzheimers Research & Therapy
- Trientine Reduces BACE1 Activity and Mitigates Amyloidosis via the AGE/RAGE/NF-κB Pathway in a Transgenic Mouse Model of Alzheimer's Disease
- (2013) Chun-Yan Wang et al. ANTIOXIDANTS & REDOX SIGNALING
- Interaction of 14-3-3ζ with Microtubule-Associated Protein Tau within Alzheimer’s Disease Neurofibrillary Tangles
- (2013) Hamid Y. Qureshi et al. BIOCHEMISTRY
- Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARβ/δ-null mice
- (2013) Emma Barroso et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Detection of an aging-related increase in advanced glycation end products in fast- and slow-twitch skeletal muscles in the rat
- (2013) B. Ramamurthy et al. BIOGERONTOLOGY
- Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid-β Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism
- (2013) Elena Kosenko et al. CNS & Neurological Disorders-Drug Targets
- Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: A pilot-study
- (2013) Josef Marksteiner et al. EXPERIMENTAL GERONTOLOGY
- Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice
- (2013) Marta Dobarro et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease
- (2013) Wenbin Wan et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway
- (2013) Xu Wang et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla)
- (2013) Sylvia E. Perez et al. JOURNAL OF COMPARATIVE NEUROLOGY
- The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose–fat diet and streptozotocin-induced diabetic nephropathy rats
- (2013) Ming-hua Zhang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Statins stimulate the production of a soluble form of the receptor for advanced glycation end products
- (2013) Patricia Quade-Lyssy et al. JOURNAL OF LIPID RESEARCH
- Reversal of Neurofibrillary Tangles and Tau-Associated Phenotype in the rTgTauEC Model of Early Alzheimer's Disease
- (2013) M. Polydoro et al. JOURNAL OF NEUROSCIENCE
- Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy
- (2013) M. Iba et al. JOURNAL OF NEUROSCIENCE
- Role of Neuroinflammation in Adult Neurogenesis and Alzheimer Disease: Therapeutic Approaches
- (2013) Almudena Fuster-Matanzo et al. MEDIATORS OF INFLAMMATION
- Molecular links between Alzheimer’s disease and diabetes mellitus
- (2013) Y. Yang et al. NEUROSCIENCE
- Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation
- (2013) S. Chen et al. NEUROSCIENCE
- Amyloid-β25–35 induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2
- (2013) Toshinari Isono et al. NEUROSCIENCE RESEARCH
- Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies
- (2013) Zhichun Chen et al. PROGRESS IN NEUROBIOLOGY
- Glycation exacerbates the neuronal toxicity of β-amyloid
- (2013) X-H Li et al. Cell Death & Disease
- Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals
- (2013) M Bomba et al. Cell Death & Disease
- Cognitive Rehabilitation in a Visual Variant of Alzheimer's Disease
- (2013) Jorge Alves et al. Applied Neuropsychology-Adult
- Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease
- (2012) Sang-Sun Yoon et al. Biomolecules & Therapeutics
- Synthesis and structure–activity relationships of tri-substituted thiazoles as RAGE antagonists for the treatment of Alzheimer’s disease
- (2012) Yun Suk Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis
- (2012) Rui Liu et al. BMC Medicine
- Hypertension Induces Brain β-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature
- (2012) Daniela Carnevale et al. HYPERTENSION
- Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer’s disease
- (2012) Furu Liang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective
- (2012) Jinlong Li et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- From Mitochondrial Dysfunction to Amyloid Beta Formation: Novel Insights into the Pathogenesis of Alzheimer’s Disease
- (2012) Kristina Leuner et al. MOLECULAR NEUROBIOLOGY
- Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE) - and amyloid beta 1-42-induced signal transduction in glial cells
- (2012) Alexander Slowik et al. Molecular Neurodegeneration
- Methylglyoxal Induces Tau Hyperphosphorylation via Promoting AGEs Formation
- (2012) Xiao-Hong Li et al. NEUROMOLECULAR MEDICINE
- Synaptic changes in Alzheimer’s disease and its models
- (2012) J. Pozueta et al. NEUROSCIENCE
- Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in assisted reproduction
- (2012) Tatiana C.S. Bonetti et al. REPRODUCTIVE BIOMEDICINE ONLINE
- NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease
- (2012) Walter J Lukiw Alzheimers Research & Therapy
- AMP-activated protein kinase: a potential player in Alzheimer’s disease
- (2011) Antero Salminen et al. JOURNAL OF NEUROCHEMISTRY
- AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation
- (2011) Xiao-Hong Li et al. NEUROBIOLOGY OF AGING
- PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
- (2010) Marwan N. Sabbagh et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Advanced glycation end products as biomarkers and gerontotoxins – A basis to explore methylglyoxal-lowering agents for Alzheimer’s disease?
- (2010) Martina Krautwald et al. EXPERIMENTAL GERONTOLOGY
- Homodimerization Is Essential for the Receptor for Advanced Glycation End Products (RAGE)-mediated Signal Transduction
- (2010) Hongliang Zong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease
- (2010) Dimitrios Kapogiannis et al. LANCET NEUROLOGY
- Brain fuel metabolism, aging, and Alzheimer’s disease
- (2010) Stephen Cunnane et al. NUTRITION
- Association between the RAGE G82S polymorphism and Alzheimer’s disease
- (2009) Keshen Li et al. JOURNAL OF NEURAL TRANSMISSION
- The sour side of neurodegenerative disorders: the effects of protein glycation
- (2009) Hugo Vicente Miranda et al. JOURNAL OF PATHOLOGY
- Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus
- (2009) Tony Valente et al. NEUROBIOLOGY OF DISEASE
- Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay
- (2008) Xiuping Chen et al. CELL BIOCHEMISTRY AND FUNCTION
- Possible Involvement of Advanced Glycation End-Products (AGEs) in the Pathogenesis of Alzheimers Disease
- (2008) Masayoshi Takeuchi et al. CURRENT PHARMACEUTICAL DESIGN
- S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells
- (2008) Giuseppe Esposito et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease
- (2008) Jonghan Shin et al. NEUROIMAGE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now